LeonaBio Inc.

LONA | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.77

-$0.17 (-3.44%)

Nov 2, 2026, 1:27 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.44%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

27.5

+4.5 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #853/1028 (Top 83%)

Full Analysis

Key Statistics

Market Data

Market Cap $18.81M

1D Range

4.77 5.20

52W Range

2.87 11.68

Valuation (TTM)

PE -0.15

PB 0.56

EV/EBITDA 0.59

Valuation (NTM)

Forward PE N/A

Forward PEG 0.07

Price Target $17.50

Cash Flow

FCF Yield -328.5%

SBC Adj. FCF Yield -364.1%

SBC Impact -10.8%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -5.7% | -6.2%

FCF 3Y | 5Y 23.7% | 3.3%

Returns

ROA -248.6%

ROE -411.6%

ROIC -248.2%

Financial Health

Net Cash

$50.49M

Current Ratio 7.01

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

LeonaBio, Inc. operates as a biopharmaceutical firm engaged in clinical-stage development. Its core mission revolves around crafting small molecule therapies aimed at revitalizing neurological functio...

Sector Healthcare

Industry Biotechnology

Employees 19

IPO Date Sep 18, 2020

Website leonabio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$17.50

Upside

+266.88%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞